While the potential benefits are significant, there are also risks associated with using nanotechnology in treating autoimmune diseases. The primary concern is the toxicity of nanoparticles, which can vary depending on their size, shape, and surface chemistry. Long-term studies are required to fully understand the potential side effects and ensure the safety of these novel therapies.
